# Moderna (MRNA) — Overview

MRNA · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mrna

## Price

Last close $213.81 on Oct 16, 2026. 52-week range $22.36 – $236.50.

## Company profile

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $2.2B |
| Revenue (quarter) | $145.0M |
| Revenue growth (year over year) | 2.11% |
| Gross profit (trailing twelve months) | $521.0M |
| Gross margin | 23.38% |
| Net income (trailing twelve months) | −$3.2B |
| Net income (quarter) | −$782.0M |
| Net income growth (year over year) | 5.21% |
| Net margin | -141.43% |
| Return on equity | -39.00% |
| EPS (trailing twelve months) | −$7.98 |
| Book value per share | $16.94 |
| P/E (trailing twelve months) | — |
| Price to book | 12.5 |
| Debt to assets | 38.32% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Moderna (MRNA) profitable?

No. Moderna reported a net loss of $3.2B over the trailing twelve months.

### How much revenue does Moderna (MRNA) make?

Moderna generated $2.2B in revenue over the trailing twelve months, up 2.11% year over year.

### How do I buy stock in Moderna (MRNA)?

MRNA trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [NVAX](https://www.lighthorse.io/tickers/nvax) — Novavax, Inc. - Common Stock
- [JNJ](https://www.lighthorse.io/tickers/jnj) — Johnson & Johnson Common Stock
- [AZN](https://www.lighthorse.io/tickers/azn) — AstraZeneca PLC Ordinary Shares
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [OCGN](https://www.lighthorse.io/tickers/ocgn) — Ocugen, Inc. - Common Stock
- [TSLA](https://www.lighthorse.io/tickers/tsla) — Tesla, Inc.  - Common Stock
- [REGN](https://www.lighthorse.io/tickers/regn) — Regeneron Pharmaceuticals, Inc. - Common Stock
- [HOOD](https://www.lighthorse.io/tickers/hood) — Robinhood Markets, Inc. - Class A Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).